InsiderSignal.AI

InsiderSignal.ai

ZIVO - Zivo Bioscience, Inc.

Insider Purchase by Maggiore Christopher D. (Dir, 10%)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

4 months ago, Maggiore Christopher D., serving as Dir, 10% owner at Zivo Bioscience, Inc. (ZIVO), purchased 23,682 shares at $12.01 per share, for a total transaction value of $284,421.00. Following this transaction, Maggiore Christopher D. now holds 517,526 shares of ZIVO.

This purchase represents a 5.00% increase in Maggiore Christopher D.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, October 8, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 9, 2025, 1 day after the trade was made.

Zivo Bioscience, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Maggiore Christopher D.

Dir, 10%

Christopher D. Maggiore (age 59) is an independent Class I director of Zivo Bioscience, Inc. (ZIVO), appointed in August 2013, and serves on the Audit and Compensation Committees.[[1]](https://fintool.com/app/research/companies/ZIVO/people/christopher-d-maggiore) As a 10% owner, he recently purchased 23,682 shares on October 8, 2025, at $12.01 per share, totaling $284,420, increasing his direct ownership to 517,526 shares; prior trades include a buy of 3,764 shares on June 11, 2024.[[2]](https://www.itiger.com/news/2574911111)[[3]](https://www.investing.com/news/insider-trading-news/maggiore-buys-284k-in-zivo-bioscience-shares-93CH-4280538)[[6]](https://www.nasdaq.com/market-activity/insiders/maggiore-christopher-d-781295) Maggiore is a private investor with over 37 years of experience in real estate development and business building, owning and managing a portfolio of private businesses and investments.[[1]](https://fintool.com/app/research/companies/ZIVO/people/christopher-d-maggiore) The Zivo Board deems him independent under Nasdaq standards, valuing his entrepreneurial and operating expertise; he attended at least 75% of board and committee meetings in 2024 and received $53,784 in fees (unpaid) plus stock awards.[[1]](https://fintool.com/app/research/companies/ZIVO/people/christopher-d-maggiore)

View full insider profile →

Trade Price

$12.01

Quantity

23,682

Total Value

$284,421.00

Shares Owned

517,526

Trade Date

Wednesday, October 8, 2025

137 days ago

SEC Filing Date

Thursday, October 9, 2025

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Zivo Bioscience, Inc.

Company Overview

No company information available
View news mentioning ZIVO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/691820

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime